\r\n \r","showSummary":null,"url":"/otc/iom-weighs-vitamin-d-calcium-intake","date":"2010-11-30T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":null,"topics":[{"name":"News","url":"/news"},{"name":"Pharmacy Technology","url":"/pharmacy-technology"},{"name":"HEALTH","url":"/health"},{"name":"Retail Clinics","url":"/retail-clinics"},{"name":"INSIGHTS AND PERSPECTIVES","url":"/insights-and-perspectives"},{"name":"Regulatory and Washington","url":"/regulatory-and-washington"}],"attachedFiles":[]},{"title":"Perrigo, Synthon to launch generic Xyzal","id":33099,"bundle":"article","summary":"
ALLEGAN, Mich. — The Food and Drug Administration has granted market exclusivity for a generic version of a medication designed to treat indoor and outdoor allergies.
\r\n
Perrigo said Monday that its licensor and supplier Synthon received regulatory approval for levocetirizine tablets, a generic version of UCB/Sepracor's Xyzal, which is marketed in the United States by Sanofi-Aventis.
\r\n
The levocetirizine tablet is the only approved generic product having a label containing all indications, Perrigo said.
","showSummary":null,"url":"/pharmacy/perrigo-synthon-launch-generic-xyzal","date":"2010-11-30T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":null,"topics":[{"name":"News","url":"/news"},{"name":"PHARMACY","url":"/pharmacy"},{"name":"Generics","url":"/generics"},{"name":"Retail Clinics","url":"/retail-clinics"},{"name":"Regulatory and Washington","url":"/regulatory-and-washington"},{"name":"New Products","url":"/new-products"}],"attachedFiles":[]},{"title":"Caltrate Soft Chews hit retail","id":33104,"bundle":"article","summary":"
MADISON, N.J. — On the same day that the Institute of Medicine increased the daily recommended intake of vitamin D to maintain bone health, Pfizer Consumer Healthcare Tuesday announced the launch of Caltrate Soft Chews, which incorporate the higher daily recommended vitamin D goals. \r\n \r","showSummary":null,"url":"/otc/caltrate-soft-chews-hit-retail","date":"2010-11-30T00:00:00","author":{"email":null,"uname":"Anonymous","firstName":null,"lastName":null,"bio":null,"title":null,"picture":null,"phone":null,"contactForm":null},"digitalEdition":null,"sponsored":false,"taggedPro":null,"teaserImage":{"id":55952,"url":"https://assets1.drugstorenews.com/styles/secondary_articles_short/s3/teaser_image_352743.jpg?itok=1fp1i-Ud","width":2156,"height":1763,"alt":null},"topics":[{"name":"News","url":"/news"},{"name":"RETAIL NEWS","url":"/retail-news"},{"name":"HEALTH","url":"/health"},{"name":"Retail Clinics","url":"/retail-clinics"},{"name":"New Products","url":"/new-products"}],"attachedFiles":[]}]},"title":"Retail Clinics","contentParagraphs":null,"sections":null};
const country = "US";
const language = null;
const SITE_LANGUAGE = "en";
const siteName = "Drug Store News";
const userRoles = ["anonymous"];
const userUid = 0;
const indexName = "dsnews";
const title = "Retail Clinics | Drug Store News";
window.dataLayer = window.dataLayer || [];
const data = {};
data.entityTaxonomy = {};
const contentTypes = [
"article",
"blog",
"bulletin",
"embed_page",
"landing_page",
"event",
"image",
"page",
"product",
"whitepaper",
"video",
"tags",
];
if (
routeInfo &&
"bundle" in routeInfo &&
contentTypes.includes(routeInfo["bundle"])
) {
data.entityBundle = routeInfo.bundle;
data.entityTitle = title || `${routeInfo.title} | ${siteName}`;
data.entityId = routeInfo.id;
data.entityName = routeInfo.author?.uname;
data.entityCreated = routeInfo.created;
data.sponsored = routeInfo.sponsored;
data.sponsor = routeInfo.sponsoringCompany;
data.entityType = "node";
data.entityLangcode = SITE_LANGUAGE;
data.siteName = siteName;
data.drupalLanguage = language;
data.drupalCountry = country;
data.userRoles = userRoles;
data.userUid = userUid;
data.entityTaxonomyKeys = {};
data.entityTaxonomyHierarchies = {};
data.parentNaicsCode = {};
data.isPro = false;
data.algoliaIndexName = indexName;
// Add toxonomy data
const taxonomies = {
businessTopic: "business_topic",
contentType: "content_type",
company: "company",
marketSegment: "market_segment",
};
const getHierarchy = (term, terms = []) => {
terms.push({ id: term.id, name: term.name });
if (term.parentTerm != null) {
getHierarchy(term.parentTerm, terms);
}
return terms;
};
const getTerms = (term, useApiId = false) => {
return { id: useApiId ? term.apiId : term.id, name: term.name };
};
const getKeys = (term) => {
return { id: term.id, name: term.apiId };
};
Object.entries(taxonomies).forEach(([key, item]) => {
terms = routeInfo[key];
if (terms && terms.length > 0) {
data["entityTaxonomy"][item] = terms.map((term) =>
getTerms(term, key === "company")
);
if (key !== "company") {
data["entityTaxonomyKeys"][item] = terms.map(getKeys);
termGroups = [];
terms.forEach((term, termInd) => {
termGroups[termInd] = getHierarchy(term);
});
data["entityTaxonomyHierarchies"][item] = termGroups;
}
}
});
data["entityTaxonomy"]["tags"] = routeInfo["topics"] || [];
// Primary Topic is either the business topic or the top tag.
if (routeInfo["businessTopic"]?.length > 0) {
data["entityPrimaryTopic"] = routeInfo["businessTopic"][0]["name"];
} else {
if (routeInfo["topics"]?.length > 0) {
data["entityPrimaryTopic"] = routeInfo["topics"][0]["name"];
}
}
// Primary and secondary entityNaicsCodes come from the MarketSegment
if (routeInfo.marketSegment?.length > 0) {
data.entityNaicsCode = {};
data["entityNaicsCode"]["id"] = routeInfo["marketSegment"][0]["id"];
data["entityNaicsCode"]["name"] =
routeInfo["marketSegment"][0]["naicsCode"];
if (routeInfo["marketSegment"][0]["parentTerm"] != null) {
data["parentNaicsCode"]["id"] =
routeInfo["marketSegment"][0]["parentTerm"]["id"];
data["parentNaicsCode"]["name"] =
routeInfo["marketSegment"][0]["parentTerm"]["naicsCode"];
}
} else {
data.entityNaicsCode = [];
}
if (routeInfo.taggedPro) {
data.isPro = routeInfo.taggedPro;
}
window.dataLayer.push(data);
} else if (routeInfo && "vid" in routeInfo) {
data.entityBundle = "tags";
data.entityTitle = routeInfo.name;
data.entityId = routeInfo.id;
data.entityName = routeInfo.author?.uname;
data.entityCreated = routeInfo.created;
data.entityType = "taxonomy_term";
data.entityLangcode = SITE_LANGUAGE;
data.siteName = siteName;
data.sponsored = routeInfo.sponsored;
data.sponsor = routeInfo.sponsoringCompany;
data.drupalLanguage = language;
data.drupalCountry = country;
data.userRoles = userRoles;
data.userUid = userUid;
data.algoliaIndexName = indexName;
data["entityTaxonomy"]["tags"] = {
id: routeInfo["id"],
name: routeInfo["name"],
};
window.dataLayer.push(data);
}
})();
LONDON — Daily aspirin use may curb cancer-related deaths, according to a new study published in The Lancet.
The study, led by Peter Rothwell of the University of Oxford and colleagues, analyzed data from eight eligible trials — which typically lasted about four years — and included more than 25,000 subjects. Among them, 674 died from cancer.
ATLANTA — The Centers for Disease Control and Prevention has set aside the week of Dec. 5 to observe this season's National Influenza Vaccination Week. The week-long emphasis on flu vaccination was established to highlight the importance of continuing influenza vaccination, as well as foster greater use of flu vaccine after the holiday season into January and beyond.
ATLANTA — In preparation for the National Influenza Vaccination Week, the Centers for Disease Control and Prevention hosted a press conference Friday afternoon to raise awareness around the universal need for people to be protected against influenza. “It’s a week that we typically highlight the importance of the flu vaccine,” Howard Koh, assistant secretary for health at the Department of Health and Human Services, told reporters. During a typical season, he said, most influenza incidents begin picking up in December.
BOSTON — According to a report in the December 2010 issue of the Harvard Health Letter, Americans are maintaining intimacy through their 60s, 70s and even 80s.
The article summed up findings from two surveys investigating intimacy health in older Americans. Indiana University researchers reported earlier this year that 20% to 30% of long-lived Americans are active into their 80s. And a University of Chicago survey originally published in 2007 found that half of Americans continue to engage well into their 70s.
ALEXANDRIA, Va. — A new study released Thursday determined that directed use of Lansinoh HPA Lanolin results in a marked reduction of nipple pain associated with breast-feeding and in significantly higher healing rates of nipple trauma compared with application of expressed breast milk. The researchers concluded that “the current recommendation for any topical treatment of sore nipples during breast-feeding should be revised in favor of HPA lanolin.”
MORRISTOWN, N.J. — Drug maker Watson Pharmaceuticals has made an emergency oral contraceptive available by prescription in the United States, the company said Wednesday.
Watson announced the launch of Ella (ulipristal acetate) in the 30-mg dose, designed to prevent pregnancy up to five days after unprotected sex or failure of other contraceptives. The drug is designed to delay ovulation for five days, the amount of time that sperm can survive in the female genital tract.
WASHINGTON — The Institute of Medicine on Tuesday issued a report on the dietary reference intake levels for vitamin D and calcium at the behest of both the U.S. and Canadian governments. IOM recommended a slight increase in vitamin D intake, but also suggested that the need for either vitamin D or calcium may be overstated.
ALLEGAN, Mich. — The Food and Drug Administration has granted market exclusivity for a generic version of a medication designed to treat indoor and outdoor allergies.
Perrigo said Monday that its licensor and supplier Synthon received regulatory approval for levocetirizine tablets, a generic version of UCB/Sepracor's Xyzal, which is marketed in the United States by Sanofi-Aventis.
The levocetirizine tablet is the only approved generic product having a label containing all indications, Perrigo said.
MADISON, N.J. — On the same day that the Institute of Medicine increased the daily recommended intake of vitamin D to maintain bone health, Pfizer Consumer Healthcare Tuesday announced the launch of Caltrate Soft Chews, which incorporate the higher daily recommended vitamin D goals.